Security Snapshot

Agomab Therapeutics NV - Common Shares, no nominal value per share Institutional Ownership

Q: What is CUSIP JYH220000?

CUSIP JYH220000 is the security identifier used in SEC filing datasets for JYH220000 - Agomab Therapeutics NV - Common Shares, no nominal value per share.

Q: Who owns JYH220000 - Agomab Therapeutics NV - Common Shares, no nominal value per share based on 13F filings?

Open this security page to review the newest available 13F ownership history, top reported holders, and period-by-period changes.

CUSIP: JYH220000

13F Institutional Holders and Ownership History

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Create free account to save this page Review latest holder period

Type / Class: Equity / Common Shares, no nominal value per share
Shares outstanding: 48,615,382

Quick Takeaways

JYH220000 - Agomab Therapeutics NV - Common Shares, no nominal value per share is tracked under CUSIP JYH220000.
Latest finished 13F holder period is not available.
2 significant owners is listed from Schedule 13D/13G reporting.

What Changed

Quarterly ownership records are not available yet for this CUSIP.
This page updates as SEC-backed holdings history becomes available.

Why This Matters

You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC Evidence

Investment Quick Answers

What is CUSIP JYH220000?
CUSIP JYH220000 identifies JYH220000 - Agomab Therapeutics NV - Common Shares, no nominal value per share in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Next ownership checks

Use the next link that matches the question you still need to answer about this security.

Latest 13F filings when you want to inspect fresh institutional portfolio moves.
Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
All institutional ownership pages to compare this security with other holder-history pages.

Significant Owners of Agomab Therapeutics NV - Common Shares, no nominal value per share based on Schedule 13D/G filings

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
FMR LLC	10%				4,873,680		FMR LLC	27 Feb 2026
Pontifax Management 4 G.P. (2015) Ltd.	6.8%				3,305,846		Pontifax VI G.P. L.P.	31 Mar 2026